Pathways - manually collected, often from reviews:
OpenBEL Selventa BEL large corpus:
EGR1
→
Complex of CEBPB-EGR1
(directlyIncreases, CEBPB/EGR1 Activity)
Zhang et al., J Biol Chem 2003* Evidence: treating HepG2 cells with OM specifically leads to prominent increases of the levels of c/EBPbeta and Egr1 bound to the LDLR promoter in vivo the N-terminal transactivation domain of Egr1 specifically interacts with c/EBPbeta The OM treatment further enhances this interaction, resulting in a large increase in the Egr1 transactivating activity Egr1 regulates LDLR transcription via a novel mechanism of protein-protein interaction with c/EBPbeta.
OpenBEL Selventa BEL large corpus:
Complex of CEBPB-EGR1
→
OSM
(increases)
Zhang et al., J Biol Chem 2003* Evidence: treating HepG2 cells with OM specifically leads to prominent increases of the levels of c/EBPbeta and Egr1 bound to the LDLR promoter in vivo the N-terminal transactivation domain of Egr1 specifically interacts with c/EBPbeta The OM treatment further enhances this interaction, resulting in a large increase in the Egr1 transactivating activity Egr1 regulates LDLR transcription via a novel mechanism of protein-protein interaction with c/EBPbeta.
Protein-Protein interactions - manually collected from original source literature:
Studies that report less than 10 interactions are marked with *